Showing 841 - 860 results of 870 for search '"prostate"', query time: 0.06s Refine Results
  1. 841

    Changes in cancer incidence and stage during the COVID-19 pandemic in 2020–2021 in the Nordic countries by Anna Johansson, Anna Skog, Tom Børge Johannesen, Tor Åge Myklebust, Simon M. Kønig, Charlotte Wessel Skovlund, Lina Steinrud Mørch, Søren Friis, Marnar Fríðheim Kristiansen, David Pettersson, Eva María Gudmundsdóttir, Nanna Margrét Kristinsdóttir, Helgi Birgisson, Sandra Irenaeus, Johan Ahlgren, Mats Lambe, Elli Hirvonen, Janne Pitkäniemi, Giske Ursin

    Published 2025-02-01
    “…Stage I breast cancer incidence declined during 2020 in Denmark/Norway/Sweden, with some catch-up in stage II incidence in 2021. Prostate cancer rates declined in Denmark/Finland/Norway/Sweden during 2020–2021, while melanoma rates declined in Finland in 2020. …”
    Get full text
    Article
  2. 842

    Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat... by Christy Ralph, Sumati Gupta, Matthew Zibelman, Brendan D Curti, Kevin J Harrington, Steven J O'Day, Andrew G Hill, David C Campbell, Gavin M Wright, David E Gerber, Jonathan E Rosenberg, Jaime R Merchan, Charles M Rudin, Hardev S Pandha, Wallace L Akerley, Daphne Day, Timothy D Clay, Ross R Jennens, Yixin Ren, Emmett V Schmidt, Lisa Guttman

    Published 2023-01-01
    “…This phase 1 study evaluated intravenous V937±pembrolizumab in patients with advanced solid tumors.Methods Patients had advanced non-small cell lung cancer (NSCLC), urothelial cancer, metastatic castration-resistant prostate cancer, or melanoma in part A (V937 monotherapy), and metastatic NSCLC or urothelial cancer in part B (V937+pembrolizumab). …”
    Get full text
    Article
  3. 843

    Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma by Metoboroghene O. Mowoe, Metoboroghene O. Mowoe, Hisham Allam, Joshua Nqada, Marc Bernon, Karan Gandhi, Sean Burmeister, Urda Kotze, Miriam Kahn, Christo Kloppers, Suba Dharshanan, Zafirah Azween, Pamela Maimela, Paul Townsend, Eduard Jonas, Jonathan M. Blackburn, Jonathan M. Blackburn

    Published 2025-01-01
    “…Specifically, we quantified the serological AAb profiles of 94 PDAC, chronic pancreatitis (CP), other pancreatic- (PC) and prostate cancers (PRC), non-ulcer dyspepsia patients (DYS), and healthy controls (HC).ResultsCombinatorial ROC curve analysis on the training cohort data from the cancer antigen microarrays identified the most effective biomarker combination as CEACAM1-DPPA2-DPPA3-MAGEA4-SRC-TPBG-XAGE3 with an AUC = 85·0% (SE = 0·828, SP = 0·684). …”
    Get full text
    Article
  4. 844

    Antispermatogenic Activity of the Benzothiazoline Ligand and Corresponding Organoantimony(V) Derivative in Male Albino Rats

    Published 2006-01-01
    “…The oral administration of both <mml:math> <mml:mtext mathvariant="bold">1a</mml:mtext> </mml:math> and <mml:math> <mml:mtext mathvariant="bold">1b</mml:mtext> </mml:math> at the dose level of 10 mg/rat/day produced significant reduction in the weights of testes, epididymides, seminal vesicles, and ventral prostate. Significant decrease in sperm motility as well as in sperm density resulted in 100% sterility. …”
    Get full text
    Article
  5. 845

    Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth by Miriam Ezcurra-Hualde, Miriam Ezcurra-Hualde, Sara Zalba, Sara Zalba, Ángela Bella, Ángela Bella, Leire Arrizabalaga, Leire Arrizabalaga, Aline Risson, Aline Risson, Román García-Fuentes, Román García-Fuentes, Celia Gomar, Celia Gomar, Nuria Ardaiz, Nuria Ardaiz, Virginia Belsue, Virginia Belsue, David Ruiz-Guillamon, David Ruiz-Guillamon, Alejandro Serrano-Alcaide, Alejandro Serrano-Alcaide, Ainara Salgado, Ainara Salgado, Fernando Aranda, Fernando Aranda, Maria J. Garrido, Maria J. Garrido, Pedro Berraondo, Pedro Berraondo, Pedro Berraondo

    Published 2025-01-01
    “…In vitro gene expression modulation was evaluated in monocytic THP-1 cells, and antiproliferative effects were assessed in HT29 (colorectal), BT474 (breast), and TRAMP-C1 (prostate) cancer cell lines. In vivo antitumor efficacy and toxicity were tested in a mouse model with subcutaneously implanted MC38 tumors. …”
    Get full text
    Article
  6. 846
  7. 847

    Effect of Benzothiazoline Ligand and Corresponding Organoantimony(V) Derivative on the Reproductive System of Male Rats

    Published 2006-01-01
    “…The oral administration of compounds <mml:math> <mml:mtext mathvariant="bold">1</mml:mtext> </mml:math> and <mml:math> <mml:mtext mathvariant="bold">2</mml:mtext> </mml:math> at the dose level of 10 mg/rat/day significantly reduced the weights of testes, epididymides, ventral prostate, and seminal vesicles. The production of preleptotene spermatocytes was decreased by <mml:math> <mml:mtext>36</mml:mtext><mml:mtext>.57%</mml:mtext> </mml:math>; <mml:math> <mml:mtext>57</mml:mtext><mml:mtext>.23%</mml:mtext> </mml:math>, pachytene spermatocytes by <mml:math> <mml:mtext>40</mml:mtext><mml:mtext>.06%</mml:mtext> </mml:math>; <mml:math> <mml:mtext>62</mml:mtext><mml:mtext>.01%</mml:mtext> </mml:math>, and secondary spermatocytes by <mml:math> <mml:mtext>52</mml:mtext><mml:mtext>.45%</mml:mtext> </mml:math>; <mml:math> <mml:mtext>63</mml:mtext><mml:mtext>.22%</mml:mtext> </mml:math>, following the treatment of compounds <mml:math> <mml:mtext mathvariant="bold">1</mml:mtext> </mml:math> and <mml:math> <mml:mtext mathvariant="bold">2</mml:mtext> </mml:math>, respectively. …”
    Get full text
    Article
  8. 848

    Clinical Remission of Chronic Refractory Pelvic Symptoms in Three Men by Bradley R. Hennenfent, Antonio Espinosa Feliciano

    Published 2004-01-01
    “…In the Manila Genitourinary Clinic, the patients were treated with microbial diagnosis, antimicrobial therapy, and 19, 27, and 21 prostatic massages respectively. All three patients underwent resolution of symptoms.…”
    Get full text
    Article
  9. 849

    Synthesis and Characterization of New Amino Acid-Schiff Bases and Studies their Effects on the Activity of ACP, PAP and NPA Enzymes (In Vitro) by Zahraa Salim M. Al-Garawi, Ivan Hameed R. Tomi, Ali Hussein R. Al-Daraji

    Published 2012-01-01
    “…Their effects on the activity of total (ACP), prostatic (PAP) and non prostatic (NPA) acid phosphatase enzymes were studied. …”
    Get full text
    Article
  10. 850

    Spontaneous Intraperitoneal Rupture of Bladder Diverticulum: A Rare Cause of Peritonitis by Ahmed Ibrahimi, Adil Kallat, Idriss Ziani, Hachem El Sayegh, Lounis Benslimane, Yassine Nouini

    Published 2020-01-01
    “…Etiologies are dominated by bladder outlet obstruction, represented mainly by benign prostatic hypertrophy (BPH) in elderly men. Clinical presentation is nonspecific, leading to delayed diagnosis and treatment. …”
    Get full text
    Article
  11. 851

    Polymyalgia Rheumatica Revealing a Lymphoma: A Two-Case Report by Frank Verhoeven, Xavier Guillot, Mickaël Chouk, Clément Prati, Daniel Wendling

    Published 2016-01-01
    “…A 73-year-old man known for prostatic neoplasia in remission for 5 years presented arthromyalgia of the limb girdle since one month. …”
    Get full text
    Article
  12. 852

    Comparison between Two Different Two-Stage Transperineal Approaches to Treat Urethral Strictures or Bladder Neck Contracture Associated with Severe Urinary Incontinence that Occurr... by A. Simonato, M. Ennas, A. Benelli, A. Gregori, F. Oneto, E. Daglio, P. Traverso, G. Carmignani

    Published 2012-01-01
    “…The recurrence of urethral/bladder neck stricture after multiple endoscopic procedures is a rare complication that can follow prostatic surgery and its treatment is still controversial. …”
    Get full text
    Article
  13. 853

    Urinary Incontinence due to Overactive Detrusor Muscle: A Rare Side Effect of Venlafaxine by Vithyalakshmi Selvaraj, Palanikumar Gunasekar, Suneel Kumar, Imad Alsakaf

    Published 2015-01-01
    “…We report a case of reemergence of urinary incontinence (UI) in a patient with benign prostatic hyperplasia (BPH) after starting treatment with venlafaxine who was stabilized on tamsulosin and finasteride for about 6 years. …”
    Get full text
    Article
  14. 854

    Doctor Alfredo Méndez Aguirre. Renowned doctor of Cienfuegos medical history in the twentieth century by Reinaldo José Pino Blanco, Rigoberto Flores Roó, Alfredo Darío Espinosa Brito

    Published 2011-04-01
    “…Analyzed through different scenarios where he acted as an eminent surgeon, we refer to his contribution to the spreading of abdominal, prostatic and gynecological surgery in Cienfuegos, besides other innovations of high importance for the Cuban Medicine at that time. …”
    Get full text
    Article
  15. 855

    Reviewing the Emergence of Lactococcus garvieae: A Case of Catheter Associated Urinary Tract Infection Caused by Lactococcus garvieae and Escherichia coli Coinfection by Tatvam T. Choksi, Farhan Dadani

    Published 2017-01-01
    “…We report a rare case of catheter associated urinary tract infection (CAUTI) caused by Lactococcus garvieae and Escherichia coli coinfection without any bacteremia in a patient with indwelling urinary catheter placed for benign prostatic hyperplasia (BPH). The patient also had a history of gastroesophageal reflux disease (GERD) with long standing famotidine treatment. …”
    Get full text
    Article
  16. 856

    The Immune Response to Tumors as a Tool toward Immunotherapy by F. Pandolfi, R. Cianci, D. Pagliari, F. Casciano, C. Bagalà, A. Astone, R. Landolfi, C. Barone

    Published 2011-01-01
    “…Herein we will review some of the recent achievement of immunotherapy in such aggressive cancers as melanoma, prostatic cancer, colorectal carcinoma, and hematologic malignancies. …”
    Get full text
    Article
  17. 857

    Canadian Laboratory Standards for Sexually Transmitted Infections: Best Practice Guidelines by Max A Chernesky, David Patrick

    Published 2005-01-01
    “…Sexually transmitted or associated syndromes such as cervicitis, enteric infections, epididymitis, genital ulcers, sexually related hepatitis, ophthalmia neonatorum, pelvic inflammatory disease, prostatitis and vulvovaginitis present a challenge for the physician to identify the microbial cause, treat the patient and manage contacts. …”
    Get full text
    Article
  18. 858

    Superficial Bladder Cancer Therapy by Emmanuel Schenkman, Donald L. Lamm

    Published 2004-01-01
    “…The initial clinical stage and grade remain the main determinant factors in survival regardless of the treatment. Prostatic urethral mucosal involvement with bladder cancer can be effectively treated with Bacillus Calmette-Guerin (BCG) intravesical immunotherapy. …”
    Get full text
    Article
  19. 859

    Monitoring Detrusor Oxygenation and Hemodynamics Noninvasively during Dysfunctional Voiding by Andrew J. Macnab, Lynn S. Stothers, Babak Shadgan

    Published 2012-01-01
    “…The current literature indicates that lower urinary tract symptoms (LUTSs) related to benign prostatic hyperplasia (BPH) have a heterogeneous pathophysiology. …”
    Get full text
    Article
  20. 860

    Penetrating Posterior Urethral Injuries: Case Report and Management Strategies by Seyed Sajjad Tabei, Brandon Lippold, Wesley Baas, Gregory Murphy

    Published 2024-01-01
    “…Unlike bladder neck injuries, immediate urethroplasty/fistula repair would be very challenging and not advised for standard prostatic or membranous injuries. Urethral catheter or suprapubic tube is recommended and can result in fistula closure and urethral patency. …”
    Get full text
    Article